Table 1.
Method | Outcome | |||
Dose range | Cure% | Euthy% | Hypo% | |
(min/max) | (min/max) | (peak/min) | (min/max) | |
Non-ablative | ||||
AbsD | 70Gy | 58% | 48% | 10% |
140Gy | 76% | 38% | 38% | |
FixA | 180 MBq | 70% | 46% | 24% |
310 MBq | 82% | 41% | 41% | |
Ablative | ||||
CalA | ~ 11.4 MBq/g | 91% | 1% | 90% |
The data is based on a combination of both models described in the text and depicted in figure 1. Minimum and maximum doses apply only to nonablative regimens. The minimum dose is at peak euthyroid rates. The maximum dose is where hypothyroid rates have caught up to euthyroid rates (making up half of the cure rates). The non-ablative cure range is 60–80% and the FixA gives superior results for cure > 70%.